window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 20, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Real World Evidence

  • Clinical Development,Clinical studies,Hematology,Regulatory Affairs,Research & Development

    MaaT Pharma publishes real-world CHRONOS data in third-line acute GvHD

    MaaT Pharma has published retrospective real-world data from its CHRONOS [...]

    April 10, 2026
  • Clinical Development,Clinical Trials,Data Management,Global health,Real world evidence

    Phesi data highlights 6.7% of global clinical trials affected by Middle East disruption

    New analysis from Phesi suggests 6.7% of globally recruiting clinical [...]

    April 8, 2026
  • Diagnostics,Hematology,Oncology,Real world evidence

    Quest Diagnostics launches flow cytometry MRD blood test for myeloma to support ultrasensitive monitoring

    Quest Diagnostics has introduced a new blood-based test for measurable [...]

    February 4, 2026
  • Chronic diseases,Clinical Development

    Rapid sepsis test linked to lower mortality and shorter hospital stays in academic centre study

    A rapid sepsis test used in the emergency department at [...]

    December 10, 2025
  • Clinical Development,Clinical studies,Data Management,Technology and platforms

    REDCap Cloud 2.0 launched to harmonize clinical trial and real-world data for AI-driven research

    REDCap Cloud has launched version 2.0, a clinical trial data [...]

    September 24, 2025
  • Biologics & Biosimilars,Chronic diseases,Clinical Development,Clinical Trials,Patient Centricity,Pharmaceuticals and therapeutics,Real world evidence,Regulatory Affairs

    Saphnelo self-administration Phase 3 trial meets primary endpoint in systemic lupus erythematosus

    AstraZeneca has reported positive interim results from the Phase 3 [...]

    September 22, 2025
  • Events and Conferences,Patient Centricity,Pharmaceuticals and therapeutics,Real world evidence,Research & Development

    EADV 2025: Almirall showcases real-world evidence and pipeline progress in dermatology

    Almirall, a global biopharmaceutical company focused on medical dermatology, has [...]

    September 22, 2025
  • Clinical Trials,Data Management,Patient Centricity,Pharmaceuticals and therapeutics,Real world evidence

    Almirall study shows psoriasis treatment improves skin and psychological well-being

    Almirall has presented new two-year results from its POSITIVE study [...]

    September 18, 2025
  • Artificial Intelligence,Clinical Development,Clinical Trials,Data Management,Drug Delivery & Formulation,Technology and platforms

    eClinical Solutions adds integrated data review plan capabilities to elluminate platform

    Company becomes the first to centralize digital data review activities [...]

    August 21, 2025
  • Clinical Trials,Data Management,Real world evidence,Regulatory Affairs

    Clinical trials: TransCelerate and FDA explore pragmatic trial designs to broaden patient access

    TransCelerate BioPharma and the US Food and Drug Administration (FDA) [...]

    August 20, 2025
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Kainova expands Phase 1/2 trial of DT-7012 with first European patient dosed
    Categories: Clinical Trials, Immunology, Oncology, Research & Development
  • Chemify founder publishes three papers on programmable chemistry and automated drug discovery
    Categories: Artificial Intelligence, Drug discovery, Research & Development, Technology and platforms
  • European liver experts highlight rising MASLD burden at EASL symposium in Budapest
    Categories: Clinical studies, Gastroenterology, Healthcare leadership, Liver disease, Metabolic Diseases
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top